On 21st, July, 2017, Anti-HIV Drug Lamivudine/Zidovudine of Shanghai Desano Bio-pharmaceutical Co., Ltd., obtained approval of WHO, which is the first anti-HIV formulation of Shanghai Desano approved by international authority. This approval is a critical milestone of Internationalization of finished products of Desano. This approval boosted our confidence and persistence in formulation development. Although there is more challenge and difficulties in the future, we are prepared for the international market of pharmaceutical formulation.